Búsqueda | Biblioteca Virtual en Salud Odontología. Uruguay

1.

Hospital Prices for Physician-Administered Drugs for Patients with Private Insurance.

Robinson, James C; Whaley, Christopher; Dhruva, Sanket S.

N Engl J Med ; 390(4): 338-345, 2024 Jan 25.

Artículo en Inglés | MEDLINE | ID: mdl-38265645

2.

Hospital Prices for Physician-Administered Drugs. Reply.

Robinson, James C; Whaley, Christopher; Dhruva, Sanket S.

N Engl J Med ; 390(14): 1347-1348, 2024 Apr 11.

Artículo en Inglés | MEDLINE | ID: mdl-38598815

3.

Association of Reference Pricing with Drug Selection and Spending.

Robinson, James C; Whaley, Christopher M; Brown, Timothy T.

N Engl J Med ; 377(7): 658-665, 2017 08 17.

Artículo en Inglés | MEDLINE | ID: mdl-28813219

4.

The Navier-Stokes regularity problem.

Robinson, James C.

Philos Trans A Math Phys Eng Sci ; 378(2174): 20190526, 2020 Jun 26.

Artículo en Inglés | MEDLINE | ID: mdl-32507084

5.

Why Is Aducanumab Priced at $56,000 per Patient? Lessons for Drug-Pricing Reform.

Robinson, James C.

N Engl J Med ; 385(22): 2017-2019, 2021 Nov 25.

Artículo en Inglés | MEDLINE | ID: mdl-34797614

6.

Reference Pricing in Germany: Implications for U.S. Pharmaceutical Purchasing.

Robinson, James C; Panteli, Dimitra; Ex, Patricia.

Issue Brief (Commonw Fund) ; 2019: 1-8, 2019 Feb 01.

Artículo en Inglés | MEDLINE | ID: mdl-30883061

7.

Lower Prices and Greater Patient Access - Lessons from Germany's Drug-Purchasing Structure.

Robinson, James C.

N Engl J Med ; 382(23): 2177-2179, 2020 Jun 04.

Artículo en Inglés | MEDLINE | ID: mdl-32492300

8.

An Innovation Surcharge to Fund the Repurposing of Generic Drugs.

Robinson, James C.

JAMA ; 2022 Nov 10.

Artículo en Inglés | MEDLINE | ID: mdl-36355357

9.

Pricing of Drugs With Evidence Development-Reply.

Robinson, James C.

JAMA ; 328(8): 778, 2022 08 23.

Artículo en Inglés | MEDLINE | ID: mdl-35997737

10.

Drug Pricing With Evidence Development.

Robinson, James C.

JAMA ; 327(16): 1545-1546, 2022 04 26.

Artículo en Inglés | MEDLINE | ID: mdl-35404379

11.

Reference Pricing, Consumer Cost-Sharing, and Insurer Spending for Advanced Imaging Tests.

Robinson, James C; Whaley, Christopher; Brown, Timothy T.

Med Care ; 54(12): 1050-1055, 2016 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-27479594

12.

Reference Pricing with Endogenous or Exogenous Payment Limits: Impacts on Insurer and Consumer Spending.

Brown, Timothy T; Robinson, James C.

Health Econ ; 25(6): 740-9, 2016 06.

Artículo en Inglés | MEDLINE | ID: mdl-25903495

13.

Funding of Pharmaceutical Innovation During and After the COVID-19 Pandemic.

Robinson, James C.

JAMA ; 325(9): 825-826, 2021 Mar 02.

Artículo en Inglés | MEDLINE | ID: mdl-33443546

14.

Sophisticated Purchasing of Pharmaceuticals: Learning From Other Countries.

Robinson, James C.

JAMA ; 324(16): 1617-1619, 2020 10 27.

Artículo en Inglés | MEDLINE | ID: mdl-32986119

15.

Total expenditures per patient in hospital-owned and physician-owned physician organizations in California.

Robinson, James C; Miller, Kelly.

JAMA ; 312(16): 1663-9, 2014.

Artículo en Inglés | MEDLINE | ID: mdl-25335148

16.

Prices and complications in hospital-based and freestanding surgery centers.

Robinson, James C; Whaley, Christopher M; Dhruva, Sanket S.

Am J Manag Care ; 30(4): 179-184, 2024 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-38603532

17.

Value-Based Pricing and Patient Access for Specialty Drugs.

Robinson, James C; Howell, Scott; Pearson, Steven D.

JAMA ; 319(21): 2169-2170, 2018 Jun 05.

Artículo en Inglés | MEDLINE | ID: mdl-29801023

18.

How Industrial Policy Could Accelerate Innovation In The Life Sciences.

Robinson, James C.

Health Aff (Millwood) ; 42(8): 1045-1053, 2023 08.

Artículo en Inglés | MEDLINE | ID: mdl-37549321

19.

Pharmacy Benefit Management: The Cost of Drug Price Rebates.

Robinson, James C.

J Law Med Ethics ; 51(S2): 52-54, 2023.

Artículo en Inglés | MEDLINE | ID: mdl-38433678

20.

Value-Based Physician Payment in Oncology: Public and Private Insurer Initiatives.

Robinson, James C.

Milbank Q ; 95(1): 184-203, 2017 03.

Artículo en Inglés | MEDLINE | ID: mdl-28266072

Biblioteca Virtual en Salud Odontología. Uruguay

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Hospital Prices for Physician-Administered Drugs for Patients with Private Insurance.

Hospital Prices for Physician-Administered Drugs. Reply.

Association of Reference Pricing with Drug Selection and Spending.

The Navier-Stokes regularity problem.

Why Is Aducanumab Priced at $56,000 per Patient? Lessons for Drug-Pricing Reform.

Reference Pricing in Germany: Implications for U.S. Pharmaceutical Purchasing.

Lower Prices and Greater Patient Access - Lessons from Germany's Drug-Purchasing Structure.

An Innovation Surcharge to Fund the Repurposing of Generic Drugs.

Pricing of Drugs With Evidence Development-Reply.

Drug Pricing With Evidence Development.

Reference Pricing, Consumer Cost-Sharing, and Insurer Spending for Advanced Imaging Tests.

Reference Pricing with Endogenous or Exogenous Payment Limits: Impacts on Insurer and Consumer Spending.

Funding of Pharmaceutical Innovation During and After the COVID-19 Pandemic.

Sophisticated Purchasing of Pharmaceuticals: Learning From Other Countries.

Total expenditures per patient in hospital-owned and physician-owned physician organizations in California.

Prices and complications in hospital-based and freestanding surgery centers.

Value-Based Pricing and Patient Access for Specialty Drugs.

How Industrial Policy Could Accelerate Innovation In The Life Sciences.

Pharmacy Benefit Management: The Cost of Drug Price Rebates.

Value-Based Physician Payment in Oncology: Public and Private Insurer Initiatives.